Lyumjev - A New Insulin Lispro for Diabetes
Date: October 19, 2020
Issue #:
1609Summary:
The FDA has approved insulin lispro-aabc (Lyumjev–
Lilly), a faster-acting formulation of insulin lispro(Humalog), for treatment of type 1 and type 2 diabetes
in adults.Fiasp, a faster-acting formulation of insulin
aspart(Novolog), was approved in 2017.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Source Type: research
More News: Diabetes | Diabetes Type 1 | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Humalog | Insulin | NovoLog